DEMO

Log In | Sign Up



ConvaTec Group

Selected Articles

2025-08-07
ETF Daily News
ConvaTec Group (OTCMKTS:CNVVY) Stock Price Down 0.2% – What's Next?
2025-08-02
ETF Daily News
ConvaTec Group's (CTEC) "Overweight" Rating Reiterated at JPMorgan Chase & Co.
2025-08-01
ETF Daily News
ConvaTec Group (LON:CTEC) Given "Add" Rating at Peel Hunt
2025-08-01
ETF Daily News
ConvaTec Group (LON:CTEC) Given Buy Rating at Deutsche Bank Aktiengesellschaft
2025-07-14
PR Newswire UK
Advanced Wound Care Market worth $19.32 billion by 2030 with 7.6% CAGR | MarketsandMarkets™
2025-07-11
ETF Daily News
JPMorgan Chase & Co. Reaffirms Overweight Rating for ConvaTec Group (LON:CTEC)
2025-07-07
GlobeNewswire
Wound Care Centers Market Report 2025-2030, with Profiles of Smith & Nephew, 3M, Molnlycke Health Care, ConvaTec, Coloplast, Medline, Integra LifeSciences, B. Braun, Cardinal Health, & Derma Sciences
2025-07-04
ETF Daily News
ConvaTec Group (LON:CTEC) Receives "Buy" Rating from Deutsche Bank Aktiengesellschaft
2025-06-30
GlobeNewswire
Europe Compression Bandages Market Size and Share Outlook 2025-2034 - Breakthrough Wound Care Solutions and Advanced Technologies Drive Market Growth
2025-06-16
GlobeNewswire
Disposable Ostomy Bags Market: Discovering the Next Major Healthcare Innovation

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom. GB00BD3VFW73 www.convatecgroup.com